Trial Profile
Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2007
Price :
$35
*
At a glance
- Drugs Octreotide (Primary) ; Terlipressin (Primary)
- Indications Variceal haemorrhage
- Focus Therapeutic Use
- 28 Sep 2007 New trial record.